Observations placeholder
Erlotinib hydrochloride
Identifier
018958
Type of Spiritual Experience
Background
A description of the experience
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
On Dec, 14, 2015: 4,693 people reported to have side effects when taking Erlotinib hydrochloride. Among them, 15 people (0.32%) have Hallucination.
Time on Erlotinib hydrochloride when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination0.00%100.00%0.00%0.00%0.00%0.00%0.00%
On Nov, 22, 2015: 4,693 people reported to have side effects when taking Erlotinib hydrochloride. Among them, 1,219 people (25.97%) have Death.
Time on Erlotinib hydrochloride when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death34.54%49.01%8.22%5.59%2.63%0.00%0.00